Purinergic receptor agonist

This page covers all Purinergic receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting P2X receptors, P2Y receptors, P1 receptors (adenosine receptors).

Targets

P2X receptors, P2Y receptors, P1 receptors (adenosine receptors)

Phase 3 pipeline (1)

• Adenosine 5'-triphosphate · McMaster University · Wound healing / Tissue repair / Immunology
  Adenosine 5'-triphosphate (ATP) acts as an extracellular signaling molecule that binds to purinergic receptors (P2 and P1 receptors) to modulate immune and inflammatory responses.

Patent intelligence

• purinergic receptor agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates